MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)
Clinical trial NCT02949908 · TERMINATED
Trial details
- NCT number
- NCT02949908
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2017-02-09
- Primary completion
- 2017-08-25
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.